Speaker Profile
PMWC PIONEER AWARD
Groundbreaking Work in Cancer Immunotherapy and the Development of T Cell Receptor (TCR) Therapies for Various Cancers
MD, Professor, Fred Hutchinson
Biography
Stanley Riddell is a physician scientist at the Fred Hutchinson Cancer Center where he has contributed to the development of genemodified cell therapies for cancer. Riddell trained in medical oncology and joined the faculty at the Fred Hutchinson Cancer Center, where he established his research program. Throughout his career, Riddell has been a pioneer in the field of genemodified cell therapies, particularly CART cells. His research has focused on genetically modifying T cells to attack cancer, which has shown remarkable promise in treating leukemia and lymphoma. Riddell has also made significant contributions to the field of stem cell transplantation where he developed innovative strategies to reduce graftversushost disease. Riddell's research has earned him numerous awards and honors. He is a recipient a Research Professor of the American Cancer Society, the International Society for Biological Therapy Team Science Award, and a Hans Fischer Senior Fellow Award at the Technical University of Munich.
Session Abstract – PMWC 2024 Silicon Valley
Track Chair: Sharon Benzeno, Adaptive Biotechnologies
- PMWC 2024 Award Ceremony
Pioneer Honoree: Stanley Riddell, Fred Hutchinson
Pioneer Honoree: George Coukos, Ludwig Cancer Center
- Keynote: Engineering Synthetic T Cell States for Cancer Rejection
- George Coukos, Ludwig Cancer Center
- Discovery of Novel Targets in Cell Therapies in Oncology and Autoimmune Disorders (PANEL)
Chair: Harlan Robins, Adaptive Bio
- Stanley Riddell, Fred Hutchinson
- Allison Betof Warner, Stanford
- Lawrence Fong, UCSF - Supply Chain 2.0 Getting Cell Therapies to Patients (PANEL)
Chair: Jean Xu, Janssen Pharmaceuticals
- Amanda Pace, Sonoma Bio
- Laura Deschenes, Sana Biotechnology - Evolving Case Law and Practical Strategies for Immunotherapy Patents
- Janet Xiao, Morrison & Foerster LLP
- Emerging Clinical Data in Oncology Cell Therapeutics
Chair: Andrew Allen, Gritstone bio, Inc.
- Robert Meehan, Moderna - Scientific Advancements in Individualized Cell Therapies in Oncology ( PANEL)
Chair: Sharon Benzeno, Adaptive Biotechnologies
- Ira Mellman, Genenetch
- Robert Meehan, Moderna
- Dirk Nagorsen, Affini-T Therapeutics - AI-Enhanced Approaches in Cell Therapy Development
Chair: Suchit Jhunjhunwala, Genentech
- Brian Weitzner, Outpace Bio
- PMWC Showcase
- Arun Wiita, UCSF
